Sponsor Spotlight: SynCardia Systems, Inc. (Part 1)

Ron Hebshie
Post Image

We collaborate with a select group of highly regarded corporate sponsors, including world-renowned lab equipment suppliers, scientific technology companies and medical device manufacturers. While sponsorships help provide free access to materials that would typically be available only through subscription, acceptance of an article for publication in JoVE is solely dependent on its scientific content and is subject to all standard editorial criteria, including peer review.

Pictured: 70cc and 50 cc syncardia temporary Total Artificial Hearts

SPOTLIGHT ON: SynCardia temporary Total Artificial Heart

JoVE VIDEO ARTICLE: Implantation of the SynCardia Total Artificial Heart

DATE PUBLISHED: July 18, 2014

JoVE JOURNAL SECTION: Clinical and Translational Medicine (CTM)

Heart failure is a chronic and progressive disease suffered by millions of people around the world. Symptoms can range from relatively mild to severe end stage biventricular failure, where both sides of the heart are incapable of pumping enough blood to sustain the body.  In these extreme instances, there are two treatment options available: an immediate transplant of a donor heart or, as a bridge to transplant, the SynCardia temporary Total Artificial Heart.

Artificial Heart and Human Heart JoVE

Once it is determined that a heart transplant is medically necessary, a patient will typically be added to the waiting list for a donor heart. On any given day, about 3,800 people in the United States are on that list. The catch? Only 2,200 donor hearts are available each year. That means a wait of a year or more for almost half of those on the list.When a donor heart is not immediately available, the SynCardia Total Artificial Heart may be an option for some patients. It is the world’s first and only FDA-approved total artificial heart and is currently approved as a bridge to transplant for transplant-eligible patients at risk of imminent death from biventricular failure.

Operative techniques for implantation of the SynCardia Total Artificial Heart are presented in this new video article, recently published in the Clinical and Translational Medicine section of the JoVE Journal:

CLICK HERE to access the full article, including extensive supporting text, reference links and citation information.

COMING IN PART 2: Doctors at Texas Children’s Hospital make history. See the SynCardia Total Artificial Heart implantation procedure that grabbed headlines and meet the 17-year-old who is alive today because of it.